3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Lymphoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Surveys and Questionnaires
2
Mitomycin
2
Hyperthermic Intraperitoneal Chemotherapy
2
irinotecan sucrosofate
1
Specimen Handling
1
Referral and Consultation
1
Oxaliplatin
1
Observation
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Lansoprazole
1
Ipilimumab
1
Floxuridine
1
Cytoreduction Surgical Procedures
1
Clarithromycin
1
CTLA-4 Antigen
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pseudomyxoma Peritonei
×
Referral and Consultation
×
Gastrointestinal
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled